JAK1 and neoplasm: Their findings revealed that missense mutations in Janus kinase 1 (JAK1) could enhance or decrease the activity of IFN‐γ signalling pathway, thus influencing the cytotoxicity of autologous tumour‐reactive T cells within organoids.